Dalrada Financial Corporation Engages CM3 Advisory as Independent Registered Public Accounting Firm: An 8-K SEC Filing Review

On October 18, 2024, Dalrada Financial Corporation (OTCMKTS:DFCO) entered into an agreement with CM3 Advisory (“CM3”) as its independent registered public accounting firm, as outlined in a recent 8-K filing with the Securities and Exchange Commission. This move signifies a change in the company’s certifying accountant.

The filing indicates that no consultations took place between Dalrada Financial Corporation and CM3 during the transitional period, spanning the fiscal years ended June 30, 2024, and 2023, extending through October 18, 2024, regarding specific accounting principles, audit opinions, financial statements, or other critical matters. Furthermore, there were no disagreements or reportable events necessitating disclosure, as prescribed by Regulation S-K.

With this engagement, Dalrada Financial Corporation aims to strengthen its financial reporting processes and maintain transparency in its accounting practices. By partnering with CM3 Advisory, the company underscores its commitment to upholding high standards of financial oversight and governance.

Brian Bonar, an Officer and Director of Dalrada Financial Corporation, signed off on behalf of the company as per the Securities Exchange Act of 1934. This signing reaffirms the authenticity and accuracy of the report.

As highlighted in the 8-K filing, the engagement with CM3 Advisory represents a strategic decision in line with Dalrada Financial Corporation’s ongoing efforts to enhance its financial operations and credibility in the market. Such moves are fundamental to ensuring trust among stakeholders and fostering a robust foundation for future growth and development.

For more detailed information regarding this engagement, interested parties can refer to the official 8-K filing available through the Securities and Exchange Commission.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Dalrada Financial’s 8K filing here.

Dalrada Financial Company Profile

Dalrada Financial Corporation, together with its subsidiaries, operates as a technology and manufacturing company. It operates through Genefic, Dalrada Energy Services, Dalrada Precision Manufacturing, and Dalrada Technologies divisions. The Genefic division processes molecular diagnostic and antibody tests to support the diagnosis of COVID-19 and the detection of immune response to the virus; markets and sells traditional biologics and human cells, tissues, and cellular and tissue-based products; and provides prescription management, education, nursing, and total health solutions; distributes alcohol-free hand sanitizers, surface cleaners, laundry aides, antimicrobial solutions, electrostatic sprayers, face masks, gloves, and kits, as well as dispensers, stands, and ease of use packaging for the end consumers.